Marian Schini

13PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Food properties (incl. characteristics and health benefits)PharmacogenomicsPacific Peoples health policy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 23, 2026
Expected change: a new concept for monitoring patients on oral bisphosphonates.

Marian Schini, Margaret A Paggiosi, Fatma Gossiel

|Jan 19, 2026
Response to Letter to the Editor regarding "The relationship between treatment-related changes in total hip BMD measured after 12, 18, and 24 mo and fracture risk reduction in osteoporosis clinical trials: the FNIH-ASBMR-SABRE project".

Tatiane Vilaca, Marian Schini, Li-Yung Lui

|Nov 09, 2025
Randomized controlled trial of an oral gastrin receptor antagonist for the treatment of postmenopausal osteoporosis.

Marian Schini, Fatma Gossiel, Margaret A Paggiosi

|Jul 28, 2025
Treatment-related changes in total hip bone mineral density are applicable to trials of varied study designs and to drugs with differing mechanisms of action: meta-regression results from the FNIH-ASBMR SABRE study.

Tatiane Vilaca, Li-Yung Lui, Marian Schini

|Jan 29, 2025
Assessing and Managing Primary Hyperparathyroidism and Fracture Risk in England: A Survey of Medical Professionals.

Kaiyang Song, Rohit Vijjhalwar, Mo Aye

|Dec 16, 2024
The relationship between baseline bone mineral density and fracture incidence in the placebo groups of randomized controlled trials using individual patient data from the FNIH-ASBMR-SABRE project.

Marian Schini, Li-Yung Lui, Tatiane Vilaca

Pageof 3